Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty 
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
Elon Musk Says Tesla Cybercab and Optimus Production Will Start Slowly Before Rapid Growth 
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments 
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
NEW YORK, May 02, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Adeptus Health Inc. (NYSE:ADPT) who purchased shares between April 29, 2016 and March 1, 2017. The action, which was filed in the United States District Court for the Eastern District of Texas, Tyler Division, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) Adeptus had material weaknesses in its internal control over financial reporting in the areas of revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in (loss) earnings of unconsolidated joint ventures; and (2) as a result, defendants’ statements about Adeptus’ business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Shareholders have until May 9, 2017 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sa/adeptus-health-inc?wire=3.
Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Joseph Klein, Esq. Empire State Building 350 Fifth Avenue 59th floor New York, NY 10118 Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com
